Renova Therapeutics | Finanzwire

Basculer en Français

10457	Companies
219659	Keywords
149029	Articles
116146	Press releases

Home
Companies
Renova Therapeutics

BRIEF

published on 06/12/2024 at 15:05, 1 year 11 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
PRESS RELEASE

published on 06/12/2024 at 15:00, 1 year 11 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics announces exploration of new therapeutic opportunities expanding gene therapy use for diabetes and heart failure. Clinical trials and preclinical studies show promising results

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
BRIEF

published on 05/09/2024 at 03:05, 2 years ago

Renova Therapeutics Prioritizes Gene Therapy Development for Heart Failure and Type 2 Diabetes

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Treatment Type 2 Diabetes Treatment
PRESS RELEASE

published on 05/09/2024 at 03:00, 2 years ago

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics prioritizes two primary regulatory pathways for launching pivotal human trials of gene therapies to treat heart failure and type 2 diabetes mellitus

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Type 2 Diabetes Mellitus

Accesswire

Published on 05/27/2026 at 02:10, 2 hours 42 minutes ago

Western Investment Company Reports First Quarter 2026 Results and Announces Executive Personnel Changes
Published on 05/27/2026 at 01:45, 3 hours 7 minutes ago

Organto Foods Announces Record First Quarter 2026 Financial Results
Published on 05/27/2026 at 00:25, 4 hours 27 minutes ago

Revolve Reports Q3 F2026 Results Backed by Strong Progress Across North American Portfolio
Published on 05/26/2026 at 22:15, 6 hours 37 minutes ago

LaFleur Announces Bought Deal Equity Offerings for Gross Proceeds of C$8 Million
Published on 05/26/2026 at 22:01, 6 hours 51 minutes ago

Kidoz Inc. Reports Q1 2026 Financial Results with YoY Revenue Growth, Accelerating Strategic Investment in AI

View all ACCESSWIRE

EQS Group

Published on 05/26/2026 at 18:50, 10 hours 2 minutes ago

The AI Gold Rush Is Running Into a Margin Problem
Published on 05/26/2026 at 18:30, 10 hours 22 minutes ago

H2APEX publishes financial figures for the first quarter of 2026 and confirms forecast
Published on 05/26/2026 at 17:30, 11 hours 22 minutes ago

GEVELOT S.A.: Weekly declaration of share buybacks – 05/26/2026 (French only)
Published on 05/26/2026 at 16:30, 12 hours 21 minutes ago

M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
Published on 05/26/2026 at 16:15, 12 hours 37 minutes ago

R. STAHL AG Management Board member Dr. Claus Bischoff resigns from his office as Management Board member at his own request and for personal reasons and will leave by mutual agreement as of 31 May 20

Les Echos

Published on 05/26/2026 at 18:39, 10 hours 12 minutes ago

Reporting on share buyback transactions carried out on May 18, 2026
Published on 05/26/2026 at 17:45, 11 hours 7 minutes ago

EURAZEO INVESTS IN BABYLON, A FRENCH OPERATOR OF NEXT-GENERATION APARTHOTELS
Published on 05/26/2026 at 15:00, 13 hours 52 minutes ago

Resolutions Ordinary and Extraordinary General Meetings
Published on 05/26/2026 at 07:59, 20 hours 53 minutes ago

Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
Published on 05/25/2026 at 17:45, 1 day 11 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE